Printer Friendly

Bantam Pharmaceutical names new president and CEO.

M2 PHARMA-March 14, 2016-Bantam Pharmaceutical names new president and CEO

(C)2016 M2 COMMUNICATIONS

Bantam Pharmaceutical LLC, a pharmaceutical company focused on the discovery and development of compounds to treat cancer with a focus on RNA translation, has named Michael A Luther, PhD as its president and chief executive officer, effective immediately, it was reported on Friday.

Dr Luther is a bio-pharmaceutical industry executive who has leadership and management experience in the industry.

Before joining as Bantam's CEO, Dr Luther was senior vice president and general manager for the Discovery and Development Services Division for Albany Molecular Research Inc. He has more than 25 years' experience as the leader of various drug discovery and development programmes and operations for biopharmaceutical companies including GSK and Merck, where he led the advancement of multiple programmes to clinic and approval.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2016 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2016 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Date:Mar 14, 2016
Words:148
Previous Article:Ignyta recommends Phase two dose and commences Phase 1b of its RXDX-105 clinical trial.
Next Article:Poxel names Jonae R. Barnes as SVP, Investor Relations and Public Relations.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters